NEW YORK (GenomeWeb) – OncoDNA said today that it signed a distribution agreement with Providens to market and distribute its cancer genomic tests to oncologists and their patients in Croatia, Bosnia-Herzegovina, Slovenia, Serbia, Montenegro, and Macedonia.

Providens will give physicians in the region access to OncoDNA's molecular profiling technology, which combines analysis of liquid and solid biopsies for patients with metastatic cancer, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.